Tag:
Press Releases
- Threshold Pharmaceuticals Announces Its Phase 3 Trial of TH-302 in Patients With Advanced Soft Tissue Sarcoma Will Continue as Planned Following Protocol-Specified Interim Analysis
- Threshold Pharmaceuticals Announces Its Phase 3 Trial of TH-302 in Patients With Advanced Soft Tissue Sarcoma Will Continue as Planned Following Protocol-Specified Interim Analysis
- Cytori Consolidates and Restructures Its Operations, Provides Business Update
- Ebola treatment trials to be fast-tracked in West Africa
- Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM
- More Press Releases
Sponsored Links